Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Specialty Nutrition Group, Inc. Announces Winners of 2004 Golden Egg Awards(TM) at 2005 NBJ Newport Summit
Specialty Nutrition Group, Inc. announces the winners of the 2004 Golden Egg Awards™ at the 8th Annual NBJ/Newport Summit
- Specialty Nutrition Group, Inc. Announces Winners of 2004 Golden Egg Awards(TM) at 2005 NBJ Newport Summit
Specialty Nutrition Group, Inc. announces the winners of the 2004 Golden Egg Awards™ at the 8th Annual NBJ/Newport Summit
- Specialty Nutrition Group, Inc. Announces Winners of 2004 Golden Egg Awards(TM) at 2005 NBJ Newport Summit
Specialty Nutrition Group, Inc. announces the winners of the 2004 Golden Egg Awards™ at the 8th Annual NBJ/Newport Summit
- Naturade Inc. Announces Acquisitions and Financial Reorganization
Company reorganizes and the existing Naturade management team has assumed full responsibility for the sales and marketing of The Ageless Foundation, Inc. brands including Ultra-Max HGH anti-aging products and of Symbiotics, Inc. New Life Colostrum products sold through retailer, direct, international and professional channels.
- Naturade Inc. Announces Acquisitions and Financial Reorganization
Company reorganizes and the existing Naturade management team has assumed full responsibility for the sales and marketing of The Ageless Foundation, Inc. brands including Ultra-Max HGH anti-aging products and of Symbiotics, Inc. New Life Colostrum products sold through retailer, direct, international and professional channels.
- Jarrow Formulas® Hires South Florida Sales Associate
Company announces the hiring of Michael Motel as the South Florida Sales Representative for Jarrow Formulas.
- Jarrow Formulas® Hires South Florida Sales Associate
Company announces the hiring of Michael Motel as the South Florida Sales Representative for Jarrow Formulas.
- Jarrow Formulas® Hires South Florida Sales Associate
Company announces the hiring of Michael Motel as the South Florida Sales Representative for Jarrow Formulas.
- Jarrow Formulas® Hires South Florida Sales Associate
Company announces the hiring of Michael Motel as the South Florida Sales Representative for Jarrow Formulas.
- Herbalife Ltd. Announces Record Second-Quarter Results
Company reports sales of $384.7 million for the quarter, up 18.7% over prior year, with net income of $22.8 million, or $0.32 per diluted share compared to net income of $12.1 million, or $0.22 per diluted share in 2004.
- Herbalife Ltd. Announces Record Second-Quarter Results
Company reports sales of $384.7 million for the quarter, up 18.7% over prior year, with net income of $22.8 million, or $0.32 per diluted share compared to net income of $12.1 million, or $0.22 per diluted share in 2004.
- Herbalife Appoints Steve Henig to New Post of Chief Scientific Officer
Company announces the appointment of Steve Henig, Ph.D. to the newly-created post of chief scientific officer with responsibility for the company's product research and development function.
- Herbalife Appoints Steve Henig to New Post of Chief Scientific Officer
Company announces the appointment of Steve Henig, Ph.D. to the newly-created post of chief scientific officer with responsibility for the company's product research and development function.
- Herbalife Appoints Steve Henig to New Post of Chief Scientific Officer
Company announces the appointment of Steve Henig, Ph.D. to the newly-created post of chief scientific officer with responsibility for the company's product research and development function.
- Herbalife Appoints Steve Henig to New Post of Chief Scientific Officer
Company announces the appointment of Steve Henig, Ph.D. to the newly-created post of chief scientific officer with responsibility for the company's product research and development function.
- Greg Probert Promoted to President and Chief Operating Officer for Herbalife Ltd.
Company announces the promotion of Chief Operating Officer Gregory L. Probert to president and chief operating officer with overall responsibility for the company's business operations in 60 markets around the world.
- Greg Probert Promoted to President and Chief Operating Officer for Herbalife Ltd.
Company announces the promotion of Chief Operating Officer Gregory L. Probert to president and chief operating officer with overall responsibility for the company's business operations in 60 markets around the world.
- Greg Probert Promoted to President and Chief Operating Officer for Herbalife Ltd.
Company announces the promotion of Chief Operating Officer Gregory L. Probert to president and chief operating officer with overall responsibility for the company's business operations in 60 markets around the world.
- Greg Probert Promoted to President and Chief Operating Officer for Herbalife Ltd.
Company announces the promotion of Chief Operating Officer Gregory L. Probert to president and chief operating officer with overall responsibility for the company's business operations in 60 markets around the world.
- Inverness Medical Innovations Announces Second Quarter 2005 Results
For the second quarter of 2005, Inverness Medical Innovations reported adjusted cash basis net income of $9.3 million, or $0.38 per diluted share, compared to adjusted cash basis net loss of $3.5 million, or $0.18 per share, in the second quarter of 2004. The net income available to common stockholders was $3.0 million, or $0.12 per common share, compared to a net loss available to common stockholders of $6.7 million, or $0.34 per common share previous year.
- Inverness Medical Innovations Announces Second Quarter 2005 Results
For the second quarter of 2005, Inverness Medical Innovations reported adjusted cash basis net income of $9.3 million, or $0.38 per diluted share, compared to adjusted cash basis net loss of $3.5 million, or $0.18 per share, in the second quarter of 2004. The net income available to common stockholders was $3.0 million, or $0.12 per common share, compared to a net loss available to common stockholders of $6.7 million, or $0.34 per common share previous year.
- Dean Foods Company Reports Second Quarter Results
Company reports that net income from continuing operations for the second quarter of 2005 totaled $81.2 million, compared with $63.3 million in the prior year second quarter, as sales for the quarter totaled $2.6 billion, on par with the second quarter of 2004.
- Dean Foods Company Reports Second Quarter Results
Company reports that net income from continuing operations for the second quarter of 2005 totaled $81.2 million, compared with $63.3 million in the prior year second quarter, as sales for the quarter totaled $2.6 billion, on par with the second quarter of 2004.
- Minnesota Applied Research Center Expands To New Clinic Space In Edina, Minnesota
Company announces move to new offices and clinic space in the Southdale Medical Building located at 6545 France Ave S in Edina, Minnesota, adjacent to the University of Minnesota Fairview Southdale Hospital.
- Minnesota Applied Research Center Expands To New Clinic Space In Edina, Minnesota
Company announces move to new offices and clinic space in the Southdale Medical Building located at 6545 France Ave S in Edina, Minnesota, adjacent to the University of Minnesota Fairview Southdale Hospital.
- Reliv International Reports Second Quarter 2005 Results of Operations
Company reports net income of $1.98 million, or $0.12 per share (diluted), up from earnings of $1.2 million, or $0.07 per share (diluted) in the second quarter of 2004, as net sales increase 19% to reach $28.5 million in the second quarter of 2005, compared to sales of $23.9 million prior year.
- Reliv International Reports Second Quarter 2005 Results of Operations
Company reports net income of $1.98 million, or $0.12 per share (diluted), up from earnings of $1.2 million, or $0.07 per share (diluted) in the second quarter of 2004, as net sales increase 19% to reach $28.5 million in the second quarter of 2005, compared to sales of $23.9 million prior year.
- Planet Organic Closes Acquisition of 14 Store Chain
Company announces that it has closed its acquisition of Newfound Health, a profitable company with 14 franchise locations in Alberta, with a final purchase price was $1.0 million, with $500,000 in cash, $400,000 in vendor take back financing over 3 years and the balance via the issuance of 90,909 shares.
- Planet Organic Closes Acquisition of 14 Store Chain
Company announces that it has closed its acquisition of Newfound Health, a profitable company with 14 franchise locations in Alberta, with a final purchase price was $1.0 million, with $500,000 in cash, $400,000 in vendor take back financing over 3 years and the balance via the issuance of 90,909 shares.
- D.D. Williamson Increases Color Solutions
Acquisition complements D.D. Williamson’s existing colorMaker(TM) natural color line; D.D. Williamson will retain Jan Mills as Vice President, Natural Colors, for technical support and a smooth transition for customers; Mills will remain President and Owner of Artemis International, Inc.
- D.D. Williamson Increases Color Solutions
Acquisition complements D.D. Williamson’s existing colorMaker(TM) natural color line; D.D. Williamson will retain Jan Mills as Vice President, Natural Colors, for technical support and a smooth transition for customers; Mills will remain President and Owner of Artemis International, Inc.
- Unigen Pharmaceuticals Promotes Regan Miles to President and Chief Operating Officer
Company has announced the appointment of Regan D. Miles as President and Chief Operating Officer effective August 1, 2005; he was previously Executive Vice President at Unigen.
- Unigen Pharmaceuticals Promotes Regan Miles to President and Chief Operating Officer
Company has announced the appointment of Regan D. Miles as President and Chief Operating Officer effective August 1, 2005; he was previously Executive Vice President at Unigen.
- Unigen Pharmaceuticals Promotes Regan Miles to President and Chief Operating Officer
Company has announced the appointment of Regan D. Miles as President and Chief Operating Officer effective August 1, 2005; he was previously Executive Vice President at Unigen.
- Unigen Pharmaceuticals Promotes Regan Miles to President and Chief Operating Officer
Company has announced the appointment of Regan D. Miles as President and Chief Operating Officer effective August 1, 2005; he was previously Executive Vice President at Unigen.
- Vital Living Revenue Reports Second Quarter Results
Company reports quarterly revenue of $1,509,000 compared to $883,000 prior year, compared to $429,000, or $0.00 per basic and diluted share, versus a net loss in the 2004 second quarter of $16,181,000, or $0.24 per basic and diluted share.
- Vital Living Revenue Reports Second Quarter Results
Company reports quarterly revenue of $1,509,000 compared to $883,000 prior year, compared to $429,000, or $0.00 per basic and diluted share, versus a net loss in the 2004 second quarter of $16,181,000, or $0.24 per basic and diluted share.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2005 Results
Company reports a 13.1% net sales increase to $284.6 million compared to $251.7 million prior year, and EBITDA of $10.2 million versus $7.4 million last year; Comparable store sales in the second quarter of 2005 were better than expected at positive 5.4 percent compared with positive 1.5 percent in the second quarter of 2004.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2005 Results
Company reports a 13.1% net sales increase to $284.6 million compared to $251.7 million prior year, and EBITDA of $10.2 million versus $7.4 million last year; Comparable store sales in the second quarter of 2005 were better than expected at positive 5.4 percent compared with positive 1.5 percent in the second quarter of 2004.
- GNC Corporation Reports Second Quarter and First Six Months 2005 Financial Results
Company reports revenues of $333.3 million for Q2, compared to consolidated revenues of $347.7 million for the same quarter prior year; decrease in revenues of $14.4 million was primarily the result of decreases in domestic same store sales in both company-owned stores and franchise locations as well as a reduced store base. EBITDA decreased 23.0% to $31.1 million compared to $40.4 million in the prior year period.
- GNC Corporation Reports Second Quarter and First Six Months 2005 Financial Results
Company reports revenues of $333.3 million for Q2, compared to consolidated revenues of $347.7 million for the same quarter prior year; decrease in revenues of $14.4 million was primarily the result of decreases in domestic same store sales in both company-owned stores and franchise locations as well as a reduced store base. EBITDA decreased 23.0% to $31.1 million compared to $40.4 million in the prior year period.
- Spectrum Organic Products Reports Second Quarter Results
Company reports net sales of $14,409,500 compared to net sales of $12,811,400 for the same period prior year, with net income of of $396,300 versus net income of $178,400 for the second quarter of 2004.
- Spectrum Organic Products Reports Second Quarter Results
Company reports net sales of $14,409,500 compared to net sales of $12,811,400 for the same period prior year, with net income of of $396,300 versus net income of $178,400 for the second quarter of 2004.
- Cactus Botanics Increases Policosanol Production Capability
Company announces it has completed expansion of its production capabilities for Policosanol.
- Cactus Botanics Increases Policosanol Production Capability
Company announces it has completed expansion of its production capabilities for Policosanol.
- Martek Receives Favorable European Patent Ruling
Company announces that its patent on DHA (docosahexaenoic acid) oil has been upheld by the Opposition Division of the European Patent Office.
- Martek Receives Favorable European Patent Ruling
Company announces that its patent on DHA (docosahexaenoic acid) oil has been upheld by the Opposition Division of the European Patent Office.
- CV Technologies Inc.Releases Q3, 2005 Results; CVT Acquires Asian Rights to Company
Company reports net sales of $2.8 million compared to $1.2 million for the same period last year, with a loss of $446 thousand for the quarter, noting cash on hand of $7.5 million plus an accumulated inventory of
COLD-fX equivalent to $30 million in sales.
- CV Technologies Inc.Releases Q3, 2005 Results; CVT Acquires Asian Rights to Company
Company reports net sales of $2.8 million compared to $1.2 million for the same period last year, with a loss of $446 thousand for the quarter, noting cash on hand of $7.5 million plus an accumulated inventory of
COLD-fX equivalent to $30 million in sales.
- Leiner Health Products Strikes Deal With MonoSol Rx to Sell New Over-the-Counter Drug and Vitamin Strips
Leiner Health Products has signed an agreement with MonoSol Rx to exclusively sell the company's patented film technology in store brand OTC strips. Leiner also will use the same film technology in its new Shortcuts(TM) brand supplement strips.
- Leiner Health Products Strikes Deal With MonoSol Rx to Sell New Over-the-Counter Drug and Vitamin Strips
Leiner Health Products has signed an agreement with MonoSol Rx to exclusively sell the company's patented film technology in store brand OTC strips. Leiner also will use the same film technology in its new Shortcuts(TM) brand supplement strips.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Strategic GMO Testing Collaboration Provides Unique "One Stop Shop" Lab Services
Leatherhead Food International (LFI), and Genetic ID (Europe) AG have announced a strategic collaboration offer a complete range of GMO testing and comprehensive analytical services for the European food industry.
- Frutarom Strengthens Positioning in East Asia and Opens Sales and Marketing Office in Indonesia
Company announces that its subsidiary, Frutarom (UK) Ltd., has opened a sales and marketing office in Indonesia's capital city, Jakarta.
- Frutarom Strengthens Positioning in East Asia and Opens Sales and Marketing Office in Indonesia
Company announces that its subsidiary, Frutarom (UK) Ltd., has opened a sales and marketing office in Indonesia's capital city, Jakarta.
- SunOpta Announces Second Quarter Results
Company reports quarterly revenues of $103 million compared to $81 million prior year with growth led by 29.1% increase in revenues within the Company's vertically integrated natural and organic food operations. Net earnings after minority interest for the second quarter were $3,307,000 or $0.06 per diluted common share compared to $6,024,000 or $0.11 per diluted common share in the second quarter of the prior year.
- SunOpta Announces Second Quarter Results
Company reports quarterly revenues of $103 million compared to $81 million prior year with growth led by 29.1% increase in revenues within the Company's vertically integrated natural and organic food operations. Net earnings after minority interest for the second quarter were $3,307,000 or $0.06 per diluted common share compared to $6,024,000 or $0.11 per diluted common share in the second quarter of the prior year.
- Hansen Natural Reports Record Second Quarter Sales and Profits
Company reports net sales of $85.4 million for the quarter, compared to $46.1 million prior year, as net income tripled to $15.2 million, or $0.63 per diluted share on a post-split basis, from $5.1 million or $0.22 per diluted share on a post-split basis for the prior year.
- Hansen Natural Reports Record Second Quarter Sales and Profits
Company reports net sales of $85.4 million for the quarter, compared to $46.1 million prior year, as net income tripled to $15.2 million, or $0.63 per diluted share on a post-split basis, from $5.1 million or $0.22 per diluted share on a post-split basis for the prior year.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Unigen Pharmaceuticals Forms Collaboration on Novel Skin Lightening Ingredient
Company announces a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin lightening product derived from a medicinal plant.
- Mannatech, Inc. Announces Second Quarter Results
Company reports net sales for the quarter of $102.6 million, up 38% over prior year, with net income of $5.8 million, or $0.21 earnings per share, compared to $5.6 million and $0.20 earnings per share (diluted) for the previous year.
- Mannatech, Inc. Announces Second Quarter Results
Company reports net sales for the quarter of $102.6 million, up 38% over prior year, with net income of $5.8 million, or $0.21 earnings per share, compared to $5.6 million and $0.20 earnings per share (diluted) for the previous year.
- Leiner Health Products Reports First Quarter 2006 Results
Company reports net sales for the quarter of $145.6 million compared to $156.0 million prior year, and a net loss of $4.2 million, compared to a net loss of $67.8 million for the same period in fiscal 2005. The company attributes the sales decline to a soft VMS and OTC market and customers' inventory reductions. Current company activities include a transition in product mix from Vitamin E to joint care in the VMS category.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
ST. LOUIS, Aug 03, 2005 (BUSINESS WIRE) -- The Solae Company, a global leader in soy protein research and application, expanded its partnership with Henan Luohe Shineway Industry Group, China's largest meat processing company, to build and operate an isolated soy protein manufacturing facility in China.
By partnering with Shineway, The Solae Company aligns itself to be the preeminent provider of soy protein to China, while at the same time creates manufacturing efficiencies that will benefit food manufacturers around the world.
"Expanding our partnership in China makes perfect sense from a business, operations and growth standpoint," said Tony Arnold, president and CEO of The Solae Company. "We are meeting our customers' needs by providing the highest quality products at a great price."
Shineway II will enable Henan Luohe Shineway to expand its local manufacturing base and offset shipping costs and other expenses. The Solae Company's participation in this partnership will enable higher quality, more functional soy protein products to be available in China, which will help grow both business and the economies of each country.
"Our customers will benefit from this partnership because they will be receiving a superior, healthier soy product," said Mr. Wan Long, president of Shineway.
Shineway II expands The Solae Company's existing partnership with the Shineway group. In April 2004, The Solae Company and the Shineway group agreed to expand overall manufacturing capability to meet the growing global demand for soy protein. The two businesses built an innovative facility to manufacture soy protein concentrate for Shineway's use. The relationship between Shineway and its local government ties, coupled with Solae's technology to create better tasting, healthier soy protein, continues to assist Shineway in meeting the growing needs for high-quality protein by the Chinese consumer.
About The Solae Company
Headquartered in St. Louis, Missouri, The Solae Company is a global innovator in technology development and the research and application of soy protein. It serves food and beverage manufacturers, dietary supplement developers, retailers and consumers in 100 countries worldwide including the U.S. and Canada, Europe and the Middle East, Latin America and the Asia/Pacific region. The company was formed through an alliance between Bunge Limited (BG) and DuPont (DD). For more than 30 years, The Solae Company has invested in fundamental research to understand the health benefits of soy protein in order to provide better ingredients for better living. Researchers at more than 180 leading universities and research institutions have used soy protein products produced by The Solae Company in hundreds of completed and ongoing soy studies. For more about the health benefits of soy protein, including additional research and sources, please visit www.thesolaecompany.com. |